{"pmid":32351860,"pmcid":"PMC7188448","title":"Coronavirus Disease 2019 (COVID-19) Complicated by Acute Respiratory Distress Syndrome: An Internist's Perspective.","text":["Coronavirus Disease 2019 (COVID-19) Complicated by Acute Respiratory Distress Syndrome: An Internist's Perspective.","A pandemic outbreak of a novel coronavirus disease (COVID-19) that began in Wuhan, China, in December 2019 has spread rapidly to multiple countries. In the United States, the first confirmed case was reported on January 20, 2020, and since then, the number of cases is rising exponentially on a daily basis. We report a case of COVID-19 infection that presented with symptoms suggestive of pneumonia. Due to the major backlog with an immense number of pending tests, it took 48 hours for the result to come back positive, while the patient went into acute respiratory distress syndrome. We provide an internist's perspective of the difficulties encountered in terms of the available management options, as the patient progressively deteriorated on the regular medical floor prompting transfer to the intensive care unit.","Cureus","Ahmed, Taha","Shah, Ronak J","Rahim, Shab E Gul","Flores, Monica","O'Linn, Amy","32351860"],"abstract":["A pandemic outbreak of a novel coronavirus disease (COVID-19) that began in Wuhan, China, in December 2019 has spread rapidly to multiple countries. In the United States, the first confirmed case was reported on January 20, 2020, and since then, the number of cases is rising exponentially on a daily basis. We report a case of COVID-19 infection that presented with symptoms suggestive of pneumonia. Due to the major backlog with an immense number of pending tests, it took 48 hours for the result to come back positive, while the patient went into acute respiratory distress syndrome. We provide an internist's perspective of the difficulties encountered in terms of the available management options, as the patient progressively deteriorated on the regular medical floor prompting transfer to the intensive care unit."],"journal":"Cureus","authors":["Ahmed, Taha","Shah, Ronak J","Rahim, Shab E Gul","Flores, Monica","O'Linn, Amy"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32351860","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.7759/cureus.7482","keywords":["acute respiratory distress syndrome","ards","coronavirus disease 2019","corticosteroids","covid-19","nebulizer","pandemic"],"locations":["Wuhan","China","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138495582732288,"score":9.490897,"similar":[{"pmid":32375150,"title":"Fulminant Acute Kidney Injury in a Young Patient with Novel Coronavirus 2019.","text":["Fulminant Acute Kidney Injury in a Young Patient with Novel Coronavirus 2019.","Coronavirus disease 2019 (COVID-19) is a global pandemic affecting more than 200 countries and 180,000 cases in the United States. While the outbreak began in China, the number of cases outside of China exceeded those in China on March 15, 2020 and are currently rising at an exponential rate. The number of fatalities in the United States are expected to exceed more than Italy and China. The disease is characterized predominantly as an acute respiratory illness. However, preliminary data suggests that kidney is a target for the virus and deterioration of renal function was associated with poor outcomes including in-hospital mortality. We pre-sent a report of a patient with COVID-19 who presented with acute onset of symptoms and normal renal function at baseline but rapidly deteriorated resulting in death. The timing of decline in renal function correlated with his worsening clinical status. He was started on continuous veno-venous hemofiltration without signs of clinical benefit. We also present the possible mechanisms for acute kidney injury in these patients. We performed a review of the emerging literature by searching PubMed, Google Scholar, and EMBASE for studies and/or case series published on this topic. Acute kidney injury might help risk stratify critically ill patients on a fatal course of COVID-19.","Cardiorenal Med","Gopalakrishnan, Akshaya","Mossaid, Ali","Lo, Kevin Bryan","Vasudevan, Viswanath","McCullough, Peter A","Rangaswami, Janani","32375150"],"abstract":["Coronavirus disease 2019 (COVID-19) is a global pandemic affecting more than 200 countries and 180,000 cases in the United States. While the outbreak began in China, the number of cases outside of China exceeded those in China on March 15, 2020 and are currently rising at an exponential rate. The number of fatalities in the United States are expected to exceed more than Italy and China. The disease is characterized predominantly as an acute respiratory illness. However, preliminary data suggests that kidney is a target for the virus and deterioration of renal function was associated with poor outcomes including in-hospital mortality. We pre-sent a report of a patient with COVID-19 who presented with acute onset of symptoms and normal renal function at baseline but rapidly deteriorated resulting in death. The timing of decline in renal function correlated with his worsening clinical status. He was started on continuous veno-venous hemofiltration without signs of clinical benefit. We also present the possible mechanisms for acute kidney injury in these patients. We performed a review of the emerging literature by searching PubMed, Google Scholar, and EMBASE for studies and/or case series published on this topic. Acute kidney injury might help risk stratify critically ill patients on a fatal course of COVID-19."],"journal":"Cardiorenal Med","authors":["Gopalakrishnan, Akshaya","Mossaid, Ali","Lo, Kevin Bryan","Vasudevan, Viswanath","McCullough, Peter A","Rangaswami, Janani"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32375150","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1159/000508179","keywords":["ace2 receptors","acute kidney injury","continuous veno-venous hemofiltration","coronavirus disease 2019"],"locations":["United States","China","China","China","United States","Italy","China"],"countries":["United States","Italy","China"],"countries_codes":["USA|United States","ITA|Italy","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138496375455745,"score":161.54088},{"pmid":32470156,"title":"The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.","text":["The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.","Acute respiratory distress syndrome and coagulopathy played an important role in morbidity and mortality of severe COVID-19 patients. A higher frequency of PE than expected in COVID-19 patients was recently reported. The presenting symptoms for PE were untypical including dyspnea, which is one of the major symptoms in severe COVID-19, especially in those patients with ARDS. We reported two COVID-19 cases with coexisting complications of PE and ARDS, aiming to consolidate the emerging knowledge of this global health emergency and raise the awareness that the hypoxemia or severe dyspnea in COVID-19 may be related to PE and not necessarily always due to the parenchymal disease. This article is protected by copyright. All rights reserved.","J Med Virol","Li, Ting","Cheng, Guang-Shing","Pipavath, Sudhakar","Kicska, Gregory","Liu, Liangjin","Kinahan, Paul E","Wu, Wei","32470156"],"abstract":["Acute respiratory distress syndrome and coagulopathy played an important role in morbidity and mortality of severe COVID-19 patients. A higher frequency of PE than expected in COVID-19 patients was recently reported. The presenting symptoms for PE were untypical including dyspnea, which is one of the major symptoms in severe COVID-19, especially in those patients with ARDS. We reported two COVID-19 cases with coexisting complications of PE and ARDS, aiming to consolidate the emerging knowledge of this global health emergency and raise the awareness that the hypoxemia or severe dyspnea in COVID-19 may be related to PE and not necessarily always due to the parenchymal disease. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Li, Ting","Cheng, Guang-Shing","Pipavath, Sudhakar","Kicska, Gregory","Liu, Liangjin","Kinahan, Paul E","Wu, Wei"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470156","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26068","keywords":["ards","covid-19","hypoxemia","pe"],"topics":["Case Report"],"weight":1,"_version_":1668420887192272896,"score":136.36816},{"pmid":32384385,"title":"Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).","text":["Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).","BACKGROUND: Data suggest that pregnant women are not at elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or developing severe disease compared with nonpregnant patients. However, management of pregnant patients who are critically ill with coronavirus disease 2019 (COVID-19) infection is complicated by physiologic changes and other pregnancy considerations and requires balancing maternal and fetal well-being. CASE: We report the case of a patient at 28 weeks of gestation with acute respiratory distress syndrome (ARDS) from COVID-19 infection, whose deteriorating respiratory condition prompted delivery. Our patient's oxygenation and respiratory mechanics improved within hours of delivery, though she required prolonged mechanical ventilation until postpartum day 10. Neonatal swabs for SARS-CoV-2 and COVID-19 immunoglobulin (Ig) G and IgM were negative. CONCLUSION: We describe our multidisciplinary management of a preterm pregnant patient with ARDS from COVID-19 infection and her neonate.","Obstet Gynecol","Blauvelt, Christine A","Chiu, Catherine","Donovan, Anne L","Prahl, Mary","Shimotake, Thomas K","George, Ronald B","Schwartz, Brian S","Farooqi, Naghma A","Ali, Syed S","Cassidy, Arianna","Gonzalez, Juan M","Gaw, Stephanie L","32384385"],"abstract":["BACKGROUND: Data suggest that pregnant women are not at elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or developing severe disease compared with nonpregnant patients. However, management of pregnant patients who are critically ill with coronavirus disease 2019 (COVID-19) infection is complicated by physiologic changes and other pregnancy considerations and requires balancing maternal and fetal well-being. CASE: We report the case of a patient at 28 weeks of gestation with acute respiratory distress syndrome (ARDS) from COVID-19 infection, whose deteriorating respiratory condition prompted delivery. Our patient's oxygenation and respiratory mechanics improved within hours of delivery, though she required prolonged mechanical ventilation until postpartum day 10. Neonatal swabs for SARS-CoV-2 and COVID-19 immunoglobulin (Ig) G and IgM were negative. CONCLUSION: We describe our multidisciplinary management of a preterm pregnant patient with ARDS from COVID-19 infection and her neonate."],"journal":"Obstet Gynecol","authors":["Blauvelt, Christine A","Chiu, Catherine","Donovan, Anne L","Prahl, Mary","Shimotake, Thomas K","George, Ronald B","Schwartz, Brian S","Farooqi, Naghma A","Ali, Syed S","Cassidy, Arianna","Gonzalez, Juan M","Gaw, Stephanie L"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32384385","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1097/AOG.0000000000003949","topics":["Case Report"],"weight":1,"_version_":1666267276724142080,"score":136.1826},{"pmid":32004427,"pmcid":"PMC7092802","title":"First Case of 2019 Novel Coronavirus in the United States.","text":["First Case of 2019 Novel Coronavirus in the United States.","An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and management of the case, including the patient's initial mild symptoms at presentation with progression to pneumonia on day 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.","N Engl J Med","Holshue, Michelle L","DeBolt, Chas","Lindquist, Scott","Lofy, Kathy H","Wiesman, John","Bruce, Hollianne","Spitters, Christopher","Ericson, Keith","Wilkerson, Sara","Tural, Ahmet","Diaz, George","Cohn, Amanda","Fox, LeAnne","Patel, Anita","Gerber, Susan I","Kim, Lindsay","Tong, Suxiang","Lu, Xiaoyan","Lindstrom, Steve","Pallansch, Mark A","Weldon, William C","Biggs, Holly M","Uyeki, Timothy M","Pillai, Satish K","32004427"],"abstract":["An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and management of the case, including the patient's initial mild symptoms at presentation with progression to pneumonia on day 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection."],"journal":"N Engl J Med","authors":["Holshue, Michelle L","DeBolt, Chas","Lindquist, Scott","Lofy, Kathy H","Wiesman, John","Bruce, Hollianne","Spitters, Christopher","Ericson, Keith","Wilkerson, Sara","Tural, Ahmet","Diaz, George","Cohn, Amanda","Fox, LeAnne","Patel, Anita","Gerber, Susan I","Kim, Lindsay","Tong, Suxiang","Lu, Xiaoyan","Lindstrom, Steve","Pallansch, Mark A","Weldon, William C","Biggs, Holly M","Uyeki, Timothy M","Pillai, Satish K"],"date":"2020-02-01T11:00:00Z","year":2020,"_id":"32004427","source":"PubMed","week":"20205|Jan 27 - Feb 02","doi":"10.1056/NEJMoa2001191","link_comment_in":"32320565","locations":["Wuhan","China","United States","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138493061955586,"score":133.83151},{"pmid":32456368,"title":"[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].","text":["[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].","Coronavirus disease 2019 (COVID-19) has become a global public health emergency threatening people's lives around the world. Although the acute respiratory distress syndrome (ARDS) induced by COVID-19 is similar to the ARDS caused by other diseases in terms of pathophysiological basis and clinical manifestations, they are also different in many aspects, which lead to different clinical therapies. Therefore, understanding the differences and similarities of ARDS induced by COVID-19 and other diseases currently are the basis for clinicians to make decisions for the treatment of COVID-19 induced ARDS.","Zhonghua Shao Shang Za Zhi","Pan, C","Xie, J F","Qiu, H B","Yang, Y","32456368"],"abstract":["Coronavirus disease 2019 (COVID-19) has become a global public health emergency threatening people's lives around the world. Although the acute respiratory distress syndrome (ARDS) induced by COVID-19 is similar to the ARDS caused by other diseases in terms of pathophysiological basis and clinical manifestations, they are also different in many aspects, which lead to different clinical therapies. Therefore, understanding the differences and similarities of ARDS induced by COVID-19 and other diseases currently are the basis for clinicians to make decisions for the treatment of COVID-19 induced ARDS."],"journal":"Zhonghua Shao Shang Za Zhi","authors":["Pan, C","Xie, J F","Qiu, H B","Yang, Y"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32456368","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3760/cma.j.cn501120-20200407-00214","keywords":["acute respiratory distress syndrome","coronavirus disease 2019","immunomodulation","mechanical ventilation","original disease"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668141322611982336,"score":126.87312}]}